Global Information, Inc. would like to present a new market research report, "Next-Generation Sequencing Technologies: Applications and Markets Report" by Insight Pharma Reports.
In the global biomedical research arena, next-generation sequencing (NGS) is the current top subject. Not only is funding relatively abundant for the time being, but collaborative programs and consortia are plentiful as well. According to Insight pharma, "much of the benefit to date from NGS-based investigation falls in the basic research realm," however, numerous applied research areas are also beginning to show progress. As supplier and participant, virtually all NGS manufacturers have shared deep interest in diagnostic applications. Hence, collaborative programs aimed at such application types are currently in progress. While a few companies have centered their efforts on epigenetic assays in cancer, the general trend is that products in this field have been slow to emerge.
In this new study, Insight Pharma discusses key issues related to the popularity; viability and cost of next-generation sequencing applications; critical market-related topics in the field; NGS applications in applied and basic research, and the evolution of NGS applications and technologies. The report includes transcripts from interviews with industry experts as well as survey results and views from current and prospective users of next-generation sequencing.
Topics featured in the market-related issues chapter of this report include the following:
- User Survey Results
- Next-Gen Sequencing Market Size, Character, and Growth
- Translation to Diagnostics
- Next-Gen Sequencing versus the Microarray Market
- Controversial Personal Genomics Market
- Exome versus Whole Genome Sequencing